About the Taskforce for Lung Health

The Taskforce for Lung Health is a group of 30 organisations and individuals working to improve lung health in England. It also aims to raise public awareness and understanding of lung health.

The Taskforce is independent of government. It brings together representatives from 30 organisations, representing patients, health care professionals, the voluntary sector and professional associations. Read more about our members.

“This is the first time that the lung community has come together to produce a plan to bring about the transformation that we desperately need. Our five-year plan sets out our framework to improve the nation’s lung health and provide better care for people with lung disease. There is much that needs to be done to change policy and services.” Dr Alison Cook, Director of External Affairs, British Lung Foundation

Dr Alison Cook, Director of External Affairs at the British Lung Foundation, chairs the Taskforce. Read the latest terms of reference for the Taskforce (Word, 32KB). 

In 2018, we:

  • published our five-year plan setting out 43 recommendations for what changes need to be made in the next 5 years.
  • issued a call for evidence to gather existing research, data and practices in support of changes to policy and services
  • conducted research into patients’ and the public’s perceptions of lung disease. This will help to inform our future campaigning work to raise awareness about lung health. Read the key findings from this research (1MB, PDF)

In 2019, we:

  • established four working groups made up of Taskforce and Industries Forum members to drive the implementation of our recommendations. Read more about our working groups.

Industries Forum

Representatives from the pharmaceutical, diagnostics, devices and digital industries make up an Industries Forum that contributes to the work of the Taskforce.

Alison Cook, Director of External Affairs at the British Lung Foundation chairs the Industries Forum. Su Jones, NHS Engagement Partner at the Association of the British Pharmaceutical Industry also sits as an observing member on the Taskforce. Read the latest terms of reference for the Industries Forum (Word, 26KB).

In 2018 the Industries Forum provided evidence and data. Read the Industries Forum submitted evidence for prevention and diagnosis (PDF, 560KB), and treatment, management and end of life (PDF, 550KB). 

In 2019 the Industries Forum members are representing industry views in the working groups.

The Industries Forum has no editorial control over the activities of the Taskforce.

Some Industries Forum members provide financial backing to the Taskforce. This is not a condition of membership to the Industries Forum and it provides no editorial rights. No Industries Forum members have voting rights on the Taskforce. Read about the Taskforce sponsors.

You can read answers to questions you might have about the Taskforce.

Working groups

In December 2018 the Taskforce published our five-year plan to improve the nation’s lung health and provide better care for people with lung disease. We identified 43 recommendations for changes to policy and services.

To help drive forward the implementation of our recommendations we have set up four working groups in the initial priority areas of:

Early diagnosis

Chairs:

  • Dr Anand Devaraj – British Society of Thoracic Imaging
  • Dr Noel Baxter and Carol Stonham – Primary Care Respiratory Society
  • Dr Sam Hare – Royal College of Radiologists

Medicines optimisation

Chairs:

  • Sheila Edwards - British Thoracic Society
  • Dr Anna Murphy - Royal Pharmaceutical Society

Pulmonary rehabilitation

Chairs:

  • Robin Hinks – Chartered Society of Physiotherapists
  • Jess Eagelton – British Lung Foundation

Data tracking

Chairs:

  • Sarah MacFadyen – British Lung Foundation
  • Ruth Ellenby – British Thoracic Society

These areas have been selected because of the number of people they will benefit and the current opportunities to influence the delivery of the NHS Long Term Plan.

The working groups are made up of Taskforce and Industries Forum members who work together to influence policy makers, commissioners and providers to change policy and practice. The working groups will contribute to the NHS Long Term Plan Respiratory Programme Delivery Board and also monitor the progress in implementing our recommendations, share information and improve public understanding and awareness of lung disease.

Taskforce sponsors

We are grateful to the sponsors of the Taskforce. In 2019, these companies are supporting the work of the Taskforce financially but have no editorial rights:

  • AstraZeneca
  • GSK
  • Seqirus